Sintx Technologies, Inc. (SINT) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US8293927039
Sintx Technologies, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.02 m USD |
| Gross profit | 461,000.00 USD |
| Operating income | -10.72 m USD |
| EBIT | -10.36 m USD |
| Net income | -10.36 m USD |
| Diluted EPS – continuing operations | -6.16 USD |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Sintx Technologies, Inc.
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
More stocks
- Neonode Inc. (NEON)
- URBAN ONE, INC. (UONEK)
- United Health Products, Inc. (UEEC)
- Vistagen Therapeutics, Inc. (VTGN)
- PALATIN TECHNOLOGIES INC (PTN)
- Concrete Leveling Systems Inc (CLEV)
- Trio Petroleum Corp (TPET)
- Lifeward Ltd. (LFWD)
- Lexaria Bioscience Corp. (LEXX)
- AVALON HOLDINGS CORP (AWX)
- AEON Biopharma, Inc. (AEON)
- Cellectar Biosciences, Inc. (CLRB)
Not investment advice. All data without warranty, price as of 18.11.2026. Details in the risk notice.